RYTM RSI Chart
Last 7 days
-2.9%
Last 30 days
-1.1%
Last 90 days
-22.8%
Trailing 12 Months
130.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 91.9M | 0 | 0 | 0 |
2023 | 33.6M | 43.8M | 62.0M | 77.4M |
2022 | 8.3M | 13.4M | 18.5M | 23.6M |
2021 | 0 | 0 | 0 | 3.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 14, 2024 | mazabraud yann | sold | - | - | -10,375 | evp, head of international |
Apr 02, 2024 | german christopher paul | sold | -15,367 | 41.76 | -368 | corporate controller & cao |
Mar 21, 2024 | shulman joseph | sold | -735,600 | 40.34 | -18,235 | chief technical officer |
Mar 20, 2024 | german christopher paul | acquired | - | - | 1,163 | corporate controller & cao |
Mar 20, 2024 | lee jennifer kayden | sold | -707,005 | 38.7719 | -18,235 | evp, head of north america |
Mar 19, 2024 | shulman joseph | sold | -608,498 | 39.22 | -15,515 | chief technical officer |
Mar 19, 2024 | smith hunter c | sold | -608,498 | 39.22 | -15,515 | chief financial officer |
Mar 19, 2024 | mazabraud yann | sold | -627,520 | 39.22 | -16,000 | evp, head of international |
Mar 19, 2024 | cramer pamela j. | sold | -608,498 | 39.22 | -15,515 | chief human resources officer |
Mar 19, 2024 | meeker david p | sold | -1,784,270 | 39.22 | -45,494 | president and ceo |
Which funds bought or sold RYTM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -85.72 | -7,334,620 | 1,140,360 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.25 | -177,145 | 2,075,250 | -% |
May 16, 2024 | COMERICA BANK | reduced | -2.74 | -130,299 | 1,435,000 | 0.01% |
May 16, 2024 | CASTLEARK MANAGEMENT LLC | new | - | 2,768,790 | 2,768,790 | 0.12% |
May 15, 2024 | Aquatic Capital Management LLC | new | - | 372,638 | 372,638 | 0.01% |
May 15, 2024 | TWINBEECH CAPITAL LP | new | - | 984,198 | 984,198 | 0.02% |
May 15, 2024 | Quarry LP | sold off | -100 | -68,955 | - | -% |
May 15, 2024 | ADAR1 Capital Management, LLC | new | - | 537,292 | 537,292 | 0.12% |
May 15, 2024 | Frazier Life Sciences Management, L.P. | reduced | -7.64 | -14,108,400 | 94,900,500 | 4.00% |
May 15, 2024 | Polar Capital Holdings Plc | reduced | -14.29 | -15,452,500 | 64,995,000 | 0.34% |
Unveiling Rhythm Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Rhythm Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Rhythm Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
Revenue | 7.2% | 25,967,000 | 24,234,000 | 22,504,000 | 19,221,000 | 11,469,000 | 8,790,000 | 4,284,000 | 9,066,000 | 1,498,000 | - | - | - | - |
Costs and Expenses | 153.2% | 165,854,000 | 65,501,000 | 66,457,000 | 65,825,000 | 64,000,000 | 50,893,000 | 43,551,000 | 54,162,000 | 54,189,000 | 52,806,000 | 45,268,000 | 40,706,000 | 34,433,000 |
S&GA Expenses | 6.2% | 34,382,000 | 32,375,500 | 30,475,000 | 30,046,000 | 24,634,000 | 26,317,000 | 21,938,000 | 22,328,000 | 21,449,000 | 20,996,000 | 17,507,000 | 15,465,000 | 14,518,000 |
R&D Expenses | 330.4% | 128,665,000 | 29,892,500 | 33,570,000 | 33,543,000 | 37,945,000 | 23,548,000 | 21,116,000 | 31,456,000 | 32,510,000 | 31,574,000 | 27,539,000 | 25,104,000 | 19,911,000 |
EBITDA Margin | -33.4% | -2.86 | -2.14 | -2.79 | -4.00 | -5.20 | -7.40 | - | - | - | - | - | - | - |
Interest Expenses | 6.5% | 4,755,000 | 4,464,500 | 3,149,000 | 3,303,000 | 3,061,000 | - | 2,144,000 | 46,000 | - | - | - | - | - |
Income Taxes | 53.1% | 300,000 | 196,000 | 368,000 | - | - | - | - | - | - | - | -8,995,000 | -5,022,000 | 22,006,000 |
Earnings Before Taxes | -240.4% | -141,072,000 | -41,437,000 | -43,795,000 | - | -52,179,000 | -42,493,000 | -40,861,000 | - | - | -63,840,000 | - | -40,411,000 | 65,756,000 |
EBT Margin | -30.4% | -3.03 | -2.32 | -2.89 | -4.14 | -5.39 | -7.66 | -3.76 | -5.20 | -8.41 | -22.07 | - | - | - |
Net Income | -239.6% | -141,372,000 | -41,633,000 | -44,163,000 | -46,703,000 | -52,179,000 | -42,493,000 | -40,861,000 | -45,001,000 | -52,764,000 | -42,866,000 | -35,107,000 | -35,389,000 | 43,750,000 |
Net Income Margin | -24.9% | -2.98 | -2.39 | -2.99 | -4.16 | -5.37 | -7.66 | -9.80 | -13.12 | -20.08 | -22.07 | - | - | - |
Free Cashflow | -38.7% | -40,742,000 | -29,382,000 | -29,252,000 | -41,090,000 | -36,480,000 | -33,999,000 | -47,082,000 | -38,869,000 | -53,759,000 | -40,540,000 | -40,266,000 | -32,088,000 | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -22.3% | 259 | 333 | 354 | 310 | 346 | 382 | 390 | 278 | 285 | 330 | 356 | 388 | 422 | 187 | 215 | 243 | 274 | 309 | 178 | 211 | 237 |
Current Assets | -23.5% | 236 | 308 | 329 | 284 | 318 | 354 | 362 | 249 | 253 | 308 | 336 | 378 | 412 | 182 | 210 | 238 | 268 | 302 | 171 | 204 | 230 |
Cash Equivalents | -11.1% | 53.00 | 60.00 | 65.00 | 116 | 110 | 128 | 185 | 113 | 79.00 | 59.00 | 92.00 | 69.00 | 87.00 | 101 | 68.00 | 59.00 | 56.00 | 63.00 | 72.00 | 64.00 | 42.00 |
Inventory | -1.4% | 9.00 | 9.00 | 8.00 | 6.00 | 5.00 | 3.00 | - | - | - | 0.00 | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -14.3% | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 |
Liabilities | 20.9% | 197 | 163 | 157 | 128 | 126 | 118 | 108 | 82.00 | 49.00 | 45.00 | 34.00 | 37.00 | 41.00 | 21.00 | 19.00 | 18.00 | 21.00 | 28.00 | 28.00 | 29.00 | 16.00 |
Current Liabilities | -1.9% | 54.00 | 55.00 | 50.00 | 46.00 | 46.00 | 40.00 | 33.00 | 45.00 | 47.00 | 43.00 | 23.00 | 17.00 | 17.00 | 18.00 | 16.00 | 15.00 | 18.00 | 24.00 | 25.00 | 26.00 | 13.00 |
Long Term Debt | - | - | - | - | - | - | - | 73.00 | 34.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -63.7% | 62.00 | 170 | 197 | 182 | 220 | 264 | 281 | 196 | 236 | 284 | 322 | 352 | 381 | 167 | 197 | 226 | 253 | 281 | 149 | 181 | 220 |
Retained Earnings | -15.8% | -1,036 | -894 | -853 | -808 | -762 | -710 | -667 | -626 | -581 | -528 | -486 | -450 | -415 | -459 | -424 | -390 | -359 | -325 | -292 | -256 | -213 |
Additional Paid-In Capital | 3.1% | 1,098 | 1,064 | 1,051 | 991 | 982 | 974 | 949 | 823 | 818 | 813 | 808 | 803 | 797 | 626 | 621 | 616 | 613 | 606 | 441 | 438 | 434 |
Shares Outstanding | 2.6% | 61.00 | 59.00 | 59.00 | 57.00 | 57.00 | 57.00 | 51.00 | 50.00 | 50.00 | 50.00 | 49.00 | 49.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 887 | - | - | - | 188 | - | - | - | 884 | - | - | - | 828 | - | - | - | 569 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -38.7% | -40,743 | -29,383 | -29,251 | -41,090 | -36,433 | -34,000 | -46,987 | -38,809 | -53,632 | -40,472 | -40,160 | -31,840 | -33,531 | -29,122 | -27,031 | -29,729 | -36,098 | -32,221 | -33,605 | -25,546 | -31,378 |
Share Based Compensation | -10.5% | 7,767 | 8,674 | 8,612 | 8,891 | 6,376 | 5,287 | 4,796 | 5,137 | 4,611 | 4,676 | 5,268 | 5,669 | 5,191 | 4,257 | 4,695 | 3,028 | 5,475 | 2,924 | 3,035 | 3,272 | 2,644 |
Cashflow From Investing | 32.7% | 30,050 | 22,640 | -94,960 | 48,191 | 18,464 | -40,775 | -39,697 | 35,979 | 72,522 | 7,248 | 62,780 | 13,525 | -145,712 | 61,887 | 34,910 | 32,861 | 28,873 | -139,127 | 41,471 | 46,145 | 23,541 |
Cashflow From Financing | 75.1% | 4,243 | 2,423 | 73,043 | -965 | -133 | 17,365 | 158,564 | 37,500 | 399 | 100 | 413 | 383 | 165,585 | 420 | 699 | 183 | 707 | 161,963 | 697 | 498 | 316 |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenues | $ 25,967 | $ 11,469 |
Costs and expenses: | ||
Cost of sales | 2,807 | 1,421 |
Research and development | 128,665 | 37,945 |
Selling, general, and administrative | 34,382 | 24,634 |
Total costs and expenses | 165,854 | 64,000 |
Loss from operations | (139,887) | (52,531) |
Other (expense) income: | ||
Other income (expense), net | 524 | (27) |
Interest expense | (4,755) | (3,061) |
Interest income | 3,046 | 3,440 |
Total other (expense) income, net | (1,185) | 352 |
Loss before taxes | (141,072) | (52,179) |
Provision for income taxes | 300 | |
Net loss | $ (141,372) | $ (52,179) |
Net loss per share, basic (in dollars per share) | $ (2.35) | $ (0.92) |
Weighted-average common shares outstanding, basic (in shares) | 60,143,558 | 56,708,975 |
Other comprehensive loss: | ||
Net Income (Loss) | $ (141,372) | $ (52,179) |
Foreign currency translation adjustment | (71) | 21 |
Unrealized gain (loss), net on marketable securities | (244) | 65 |
Comprehensive loss | (141,687) | (52,093) |
Product revenue | ||
Total revenues | $ 25,967 | $ 11,469 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 53,428 | $ 60,081 |
Short-term investments | 147,771 | 215,765 |
Accounts receivable, net | 14,695 | 14,867 |
Inventory | 8,507 | 8,624 |
Prepaid expenses and other current assets | 11,352 | 8,931 |
Total current assets | 235,753 | 308,268 |
Property and equipment, net | 1,149 | 1,341 |
Right-of-use asset | 670 | 781 |
Intangible assets, net | 6,815 | 7,028 |
Restricted cash | 460 | 328 |
Other long-term assets | 13,804 | 14,999 |
Total assets | 258,651 | 332,745 |
Current liabilities: | ||
Accounts payable | 7,550 | 4,885 |
Accrued expenses and other current liabilities | 44,531 | 48,262 |
Deferred revenue | 1,286 | 1,286 |
Lease liability | 793 | 770 |
Total current liabilities | 54,160 | 55,203 |
Long-term liabilities: | ||
Deferred royalty obligation | 107,368 | 106,143 |
Lease liability, non-current | 284 | 490 |
Derivative liability | 660 | 1,150 |
Other long-term liabilities | 34,598 | |
Total liabilities | 197,070 | 162,986 |
Stockholders' equity: | ||
Common stock, $0.001 par value: 120,000,000 shares authorized; 59,426,559 and 56,612,429 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 60 | 59 |
Additional paid-in capital | 1,097,810 | 1,064,302 |
Accumulated other comprehensive income (loss) | (181) | 134 |
Accumulated deficit | (1,036,108) | (894,736) |
Total stockholders' equity | 61,581 | 169,759 |
Total liabilities and stockholders' equity | $ 258,651 | $ 332,745 |